(Q28266315)

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Side effects of retroviral gene transfer into hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Transcription start regions in the human genome are favored targets for MLV integration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

HIV-1 integration in the human genome favors active genes and local hotspots

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Retroviral vector insertion sites associated with dominant hematopoietic clones mark "stemness" pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaque

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Murine leukemia induced by retroviral gene marking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Safety of retroviral gene marking with a truncated NGF receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Comparative expression analysis of the antagonistic transcription factors EVI1 and MDS1-EVI1 in murine tissues and during in vitro hematopoietic differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

The role of EVI1 in normal and leukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Characterization of the PR domain of RIZ1 histone methyltransferase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Histone methyltransferases in tumor suppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Altered expression of retinoblastoma protein-interacting zinc finger gene, RIZ, in human leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Evi-1 expression in Xenopus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Evi1 is specifically expressed in the distal tubule and duct of the Xenopus pronephros and plays a role in its formation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Mutation at the Evi1 locus in Junbo mice causes susceptibility to otitis media

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

C. elegans EVI1 proto-oncogene, EGL-43, is necessary for Notch-mediated cell fate specification and regulates cell invasion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

hamlet, a binary genetic switch between single- and multiple- dendrite neuron morphology.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Expression of the Evi-1 gene in haemopoietic cells of children with juvenile myelomonocytic leukaemia and normal donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

The genetic program of hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Differential gene expression profiling of adult murine hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Interaction of EVI1 with cAMP-responsive element-binding protein-binding protein (CBP) and p300/CBP-associated factor (P/CAF) results in reversible acetylation of EVI1 and in co-localization in nuclear speckles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

The Evi1 proto-oncoprotein blocks endomitosis in megakaryocytes by inhibiting sustained cyclin-dependent kinase 2 catalytic activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

EVI1 promotes cell proliferation by interacting with BRG1 and blocking the repression of BRG1 on E2F1 activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Transforming growth factor-beta signaling in normal and malignant hematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

An early haematopoietic defect in mice lacking the transcription factor GATA-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Point mutations in two EVI1 Zn fingers abolish EVI1-GATA1 interaction and allow erythroid differentiation of murine bone marrow cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

RTCGD: retroviral tagged cancer gene database

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

EVI1 expression in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Prognostically useful gene-expression profiles in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Molecular mechanisms of leukemogenesis by AML1/EVI-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Repression of RUNX1 activity by EVI1: a new role of EVI1 in leukemogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

EVI-1 gene expression in myeloid clonogenic cells from juvenile myelomonocytic leukemia (JMML)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Regulation of the expression of the oncogene EVI1 through the use of alternative mRNA 5'-ends.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

The EVI-1 gene--its role in pathogenesis of human leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Leukemogenesis of the EVI1/MEL1 gene family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

EVI1 induces myelodysplastic syndrome in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: a model for human AML

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Expression of the zinc finger gene EVI-1 in ovarian and other cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Nonhuman primate embryonic stem cells as a preclinical model for hematopoietic and vascular repair

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Hot spots of retroviral integration in human CD34+ hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Foamy virus vector integration sites in normal human cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Hematopoietic stem-cell behavior in nonhuman primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021

HOXB4-induced expansion of adult hematopoietic stem cells ex vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300372

7 January 2021